ANDA 218255, held by Zydus Pharms. Isosorbide Mononitrate.
As of Nov 16, 2026, ANDA 218255 (Isosorbide Mononitrate), held by Zydus Pharms, was first approved by FDA on Feb 15, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 15, 2024 | Original application | Approved | None posted |
| Isosorbide Mononitrate30MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate60MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate120MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters